CYCLO(7-AMINOHEPTANOYL-PHE-D-TRP-LYS-THR[BZL])
Synonym(s):Cyclosomatostatin
- CAS NO.:84211-54-1
- Empirical Formula: C44H57N7O6
- Molecular Weight: 779.97
- MDL number: MFCD00076778
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-06-30 15:45:59
What is CYCLO(7-AMINOHEPTANOYL-PHE-D-TRP-LYS-THR[BZL])?
The Uses of CYCLO(7-AMINOHEPTANOYL-PHE-D-TRP-LYS-THR[BZL])
Cyclo(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[Bzl]) has been used as a somatostatin antagonist to study its effects on sleep in rats to infer the role of endogenous somatostatin in the physiologic modulation of REM sleep (REMS) , as an somatostatin (SST) antagonist to study its effects on elemental-induced intestinal atrophy in rats , as an SST receptor antagonist to eliminate the effect of somatostatin on catecholamine .
What are the applications of Application
Cyclosomatostatin is a non-selective somatostatin receptor antagonist
Biological Activity
cyclosomatostatin is a non-selective somatostatin receptor antagonist.somatostatin is a regulatory hormone or tissue factor playing an inhibitory role in the normal regulation of several organ systems including hypothalamus and pituitary gland, central nervous system, gastrointestinal tract as well as pancreas.
Biochem/physiol Actions
Cyclo(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[Bzl]) (cSSTA) is a cyclic somatostatin (SST) analog and is a somatostatin receptor antagonist. It is involved in blocking the effect of somatostatin, such as airway β-adrenergic function and regulation of acetylcholine release. cSSTA is also involved in blocking the effect of somatostatin of hormone release and?corticotropin-releasing factor-induced suppression of gastric emptying.
in vitro
although cyclosomatostatin could fully block the effect of somatostatin, it only partially reversed the inhibitory effect of cortistatin, a new anti-inflammatory peptide. this observation was further supported by the fact that cyclosomatostatin reversed the antiinfl ammatory effect of somatostatin and octreotide in vitro completely, while only partially reversing the effect of cortistatin [1].
in vivo
the effect of cortistatin was found to be dose dependent, with dose as low as 0.5 nmol (50 μg/kg) being partially protective. in contrast, cyclosomatostatin, somatostatin as well as octreotide were not protective [1].
storage
Store at -20°C
References
[1] gonzalez-rey e,chorny a,robledo g,delgado m. cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. j exp med.2006 mar 20;203(3):563-71.
Properties of CYCLO(7-AMINOHEPTANOYL-PHE-D-TRP-LYS-THR[BZL])
Boiling point: | 1118.4±65.0 °C(Predicted) |
Density | 1.147±0.06 g/cm3(Predicted) |
storage temp. | -20°C |
solubility | H2O: 1 mg/mL, clear, colorless |
form | powder |
pka | 12.83±0.70(Predicted) |
color | white |
Safety information for CYCLO(7-AMINOHEPTANOYL-PHE-D-TRP-LYS-THR[BZL])
Computed Descriptors for CYCLO(7-AMINOHEPTANOYL-PHE-D-TRP-LYS-THR[BZL])
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Mefenamic Acid IP/BP/EP/USP Diclofenac Sodium IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
Cyclo(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[Bzl]) CAS 84211-54-1View Details
84211-54-1 -
1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%View Details
99903-60-3 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4